Dermatology practices provide medical, surgical, and cosmetic skin care services and represent one of the most attractive specialties for private equity consolidation due to high margins, strong cash-pay cosmetic revenue, and favorable demographics. The combination of medically necessary services and elective aesthetic treatments creates a resilient, dual-revenue model that performs well across economic cycles. The industry is highly fragmented with thousands of independent practices, driving continued M&A activity from both strategic and financial acquirers.
Who buys these: Private equity-backed dermatology roll-up platforms, independent physician entrepreneurs, medical groups, and strategic acquirers seeking to expand geographic footprint in the dermatology sector
4–7×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Recession Resistant
Essential service
Minimum $1M EBITDA preferred, 2+ licensed dermatologists or strong PA/NP support staff, diversified payer mix with less than 40% Medicare dependency, established patient base with recurring appointment volume, and clean malpractice history
Get Deal Flow In Your Inbox
New Dermatology Practice acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Dermatology Practice acquisition
Seller Intelligence
Who sells Dermatology Practice businesses?
Retiring dermatologists or physician founders seeking liquidity, solo practitioners looking to join a larger platform, and multi-physician practice owners pursuing partial or full exits
Typical exit timeline: 12–24 months
Dermatology Practice businesses in the $1M–$5M revenue range typically sell for 4–7× EBITDA. Minimum $1M EBITDA preferred, 2+ licensed dermatologists or strong PA/NP support staff, diversified payer mix with less than 40% Medicare dependency, established patient base with recurring appointment volume, and clean malpractice history
Dermatology Practice businesses typically trade at 4–7× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Dermatology Practice businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Asset purchase with MSO (Management Services Organization) structure to comply with corporate practice of medicine laws
Key due diligence areas include: Physician employment agreements, non-competes, and retention risk post-close; Payer contracts, reimbursement rates, and revenue cycle management quality; Malpractice claims history and current liability insurance coverage; Patient volume trends, appointment mix (medical vs. cosmetic), and no-show rates; State-specific corporate practice of medicine laws and compliance with healthcare regulations.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers